ATE128351T1 - Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen. - Google Patents

Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.

Info

Publication number
ATE128351T1
ATE128351T1 AT92910661T AT92910661T ATE128351T1 AT E128351 T1 ATE128351 T1 AT E128351T1 AT 92910661 T AT92910661 T AT 92910661T AT 92910661 T AT92910661 T AT 92910661T AT E128351 T1 ATE128351 T1 AT E128351T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
digestive tract
treating digestive
tract pain
edible pharmaceutical
Prior art date
Application number
AT92910661T
Other languages
English (en)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE128351T1 publication Critical patent/ATE128351T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92910661T 1991-04-04 1992-03-13 Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen. ATE128351T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04

Publications (1)

Publication Number Publication Date
ATE128351T1 true ATE128351T1 (de) 1995-10-15

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92910661T ATE128351T1 (de) 1991-04-04 1992-03-13 Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.

Country Status (16)

Country Link
EP (1) EP0578768B1 (de)
JP (1) JPH06506682A (de)
KR (1) KR100238565B1 (de)
AT (1) ATE128351T1 (de)
AU (1) AU665349B2 (de)
BR (1) BR9205827A (de)
CA (1) CA2106215C (de)
CZ (1) CZ282105B6 (de)
DE (1) DE69205158T2 (de)
DK (1) DK0578768T3 (de)
ES (1) ES2077417T3 (de)
GR (1) GR3017580T3 (de)
HU (1) HU213203B (de)
RU (1) RU2126249C1 (de)
SK (1) SK121293A3 (de)
WO (1) WO1992017164A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502288A (ja) * 1992-10-09 1996-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー 感昌症状を治療するための医薬組成物及び用法
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
FI955144L (fi) * 1993-04-30 1995-10-31 Procter & Gamble Päällystetyt farmaseuttiset koostumukset
PT698393E (pt) * 1993-05-19 2002-10-31 Hisamitsu Pharmaceutical Co Agente de solubilizacao e preparacao para uso externo contendo o mesmo
EP0715516A1 (de) * 1993-08-17 1996-06-12 Applied Analytical Industries, Inc. Orales h2-antagonisten präparat
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
AU8084594A (en) * 1993-10-28 1995-05-22 Procter & Gamble Company, The Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
CA2184361C (en) * 1994-03-24 2000-12-05 Francis Bernard Chapura Solid dose forms containing bismuth
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
CO4410201A1 (es) * 1994-07-20 1997-01-09 Colgate Palmolive Co Metodos y composiciones farmaceuticas para el tratamiento de transtornos gastricos
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US6627233B1 (en) 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
RU2192251C1 (ru) * 2001-05-25 2002-11-10 Дальневосточный государственный медицинский университет Способ снижения гликемии у больных сахарным диабетом ii типа с гастродуоденальными язвами
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
RU2257890C2 (ru) * 2003-10-06 2005-08-10 Марио Атилио Лос Способ получения устойчивых фармацевтических композиций в форме таблеток, содержащих омепразол, и фармацевтические композиции, полученные таким способом
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp 3−l−メントキシプロパン−1、2−ジオ−ル

Also Published As

Publication number Publication date
CA2106215C (en) 1997-05-27
RU2126249C1 (ru) 1999-02-20
JPH06506682A (ja) 1994-07-28
ES2077417T3 (es) 1995-11-16
BR9205827A (pt) 1994-06-28
CZ282105B6 (cs) 1997-05-14
EP0578768A1 (de) 1994-01-19
KR100238565B1 (ko) 2000-02-01
DE69205158T2 (de) 1996-04-18
CZ226093A3 (en) 1994-04-13
WO1992017164A1 (en) 1992-10-15
AU1761492A (en) 1992-11-02
AU665349B2 (en) 1996-01-04
DE69205158D1 (de) 1995-11-02
DK0578768T3 (da) 1996-02-05
EP0578768B1 (de) 1995-09-27
CA2106215A1 (en) 1992-10-05
GR3017580T3 (en) 1995-12-31
SK121293A3 (en) 1994-07-06
HU9302970D0 (en) 1994-01-28
HUT65881A (en) 1994-07-28
HU213203B (en) 1997-03-28

Similar Documents

Publication Publication Date Title
DE69205158D1 (de) Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
IS4397A (is) Ný lyfjablanda til meðhöndlunar á verkjum sem inniheldur staðdeyfiefni, skautuð lípíð og tríasýlglýseról
ES2082723B1 (es) Formulacion farmaceutica de fluoxetina en forma dispersable.
DE69213010D1 (de) Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
DE69432076D1 (de) Neue pharmazeutische formulierungen
ES2097155T3 (es) Forma de dosificacion efervescente y metodo de administracion.
ATE71293T1 (de) Arzneiformulierung.
SE8801732L (sv) Ny komposition
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
ATA186692A (de) Pharmazeutische zusammensetzung
SE8306367L (sv) Antidiuretiskt verkande farmaceutiskt preparat
NO20034863D0 (no) Deuterert 3-piperidinopropiofenon og medikamenter inneholdende disse
IT1311495B1 (it) Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
EA199900963A1 (ru) Лекарственные формы сертралина в виде раствора, заключенного в желатиновые капсулы
ATE238034T1 (de) Geschmacksmaskierung schlecht schmeckender formulierungen
DK344489D0 (da) Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
DE69132392D1 (de) Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen
ATE94388T1 (de) Verwendung von otiloniumbromid fuer die topische anwendung im gastrointestinaltrakt und entsprechende geeignete pharmazeutische formulierung.
RU97117568A (ru) Гастропульмин
KR900017599A (ko) 종양 치료용 약학 조성물
RU98105696A (ru) Средство для лечения и профилактики болезней полости рта
Meurer et al. Information from your family doctor: What should I know about Helicobacter pylori infections?
RU93019936A (ru) Состав, оказывающий тонизирующее действие на организм человека и теплокровных животных

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee